Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Zydus Lifesciences Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	532321
ISIN Demat	INE010B01027
Book Value	214.41

NSE Code	ZYDUSLIFE
Dividend Yield %	1.06
Market Cap	1040043.45

P/E	23.33
EPS	44.31
Face Value	1


	BSE		NSE

16-Sep-2025 16:01

Last Price	1033.60
Net Change	-3.1
% Change	-0.3%
Prev.Close	1036.70
Open	1037.35
High	1043.35
Low	1030.00
Volume	18100

Last Price	1034.50
Net Change	-2.4
% Change	-0.23%
Prev.Close	1036.90
Open	1042.00
High	1043.50
Low	1030.55
Volume	511672

Value	18708160
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1043.35
52-Week High	1135.95
52-Week Low	797.05

Value	529324684
Best Buy	1034.50
Best Sell	0.00
Best Quantity	27
Sell Quantity	0
Today's Range	1043.50
52-Week High	1133.00
52-Week Low	795.00

Open Price	1038.80
High Price	1047.00
Low Price	1035.05
Last Price	1036.95
Prev Close	1041.45
Change	-4.50
% Change	-0.43 %

Average Price	1039.64
Underlying Value	1034.50
Number of contracts traded	1520
Turnover in Rs. Lakhs	14222
Open Interest	8638200.00
Change in O I	33300.00
% Change in O I	0.39 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	27
Price	1034.50

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	1800
Price	1036.8

Quantity	900
Price	1037.3

Holding Details

Latest Corporate Events

Bonus

1 : 2

05-Apr-10

Book Closure

30-Jul-21

06-Aug-21

Dividend

1100 %

25-Jul-25

Company News

16-09-2025

Zydus Lifesciences’ arm l...

16-09-2025

Zydus Lifesciences’ arm l...

16-09-2025

Zydus Lifesciences moves ...

06-09-2025

USFDA completes inspectio...

05-09-2025

Zydus Lifesciences soars ...

04-09-2025

Zydus Lifesciences’ arm i...

02-09-2025

Zydus Lifesciences launch...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.